Übersichtsarbeit
Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata
Journal of Drugs in Dermatology · 2026
DOI: 10.36849/jdd.9292 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Drugs in Dermatology, 2026. Verfasst von Douglas DiRuggiero und 1 weiteren Autor:innen. Hauptthemen laut MEDLINE: Alopecia Areata, Janus Kinase Inhibitors. Die Arbeit wurde bisher 1-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Alopecia AreataJanus Kinase InhibitorsHumansTreatment OutcomeQuality of Life
Substanzen
Janus Kinase Inhibitors
Zitieren
APA
DiRuggiero, D., & Kucera, K. (2026). Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata. Journal of Drugs in Dermatology. https://doi.org/10.36849/jdd.9292
Vancouver
DiRuggiero D, Kucera K. Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata. Journal of Drugs in Dermatology. 2026. doi:10.36849/jdd.9292
BibTeX
@article{DiRuggiero2026,
author = {DiRuggiero, Douglas and Kucera, Kristine},
title = {Efficacy, Safety, and Real-World Aspects of Janus Kinase Inhibitors to Treat Patients With Alopecia Areata},
journal = {Journal of Drugs in Dermatology},
year = {2026},
doi = {10.36849/jdd.9292}
}
EUVIMED